PROM1 and ovarian carcinoma: In this context, few previous studies have demonstrated the existence of CSC-enriched side population of cells [28,37] or CD44, CD117, CD133, CD24 enriched population of cells in ovarian cancer cell lines or ovarian cancer patient’s samples [38-40].